9 Computational Drug Discovery Startups Using AI
Nanalyze - 25-Apr-2017Including BenevolentAI which already has 24 drug candidates. 98% of big data has only been creat...
Join the club for FREE to access the whole archive and other member benefits.
CEO & Co-Founder at twoXAR.
Prior to co-founding twoXAR, Andrew held Chief Technology Officer roles at several early stage companies where he managed teams as large as a hundred technologists distributed around the world. Andrew developed the company's proprietary algorithm and as Chief Executive Officer is focused on overall company strategy, product development and fundraising. Andrew studied biomedical informatics in Stanford University's SCPD graduate program and holds Master of Science and Bachelor of Science degrees in Computer Science from Rochester Institute of Technology.
Visit website: https://www.twoxar.com/company
See also: TwoXAR - Drug discovery and development company.
Details last updated 07-Jul-2020
Including BenevolentAI which already has 24 drug candidates. 98% of big data has only been creat...